Press release


04/04/2018
Vytrus finishes 1M capital round
CEO and Founders of Vytrus Biotech
Vytrus has succesfully finished its capital round, that started during the last trimester of 2017, obtaining new ressource, with the value of 1 million euros. This investment will allow the company to continue it's expansion strategy, including its future incorporation on a European secondary stock market.
 
 
 
 
 
Permalink  
 
Developed by Web4Bio